Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis

[1]  F. Piehl,et al.  Fatigue and depression in multiple sclerosis: pharmacological and non‐pharmacological interventions , 2016, Acta neurologica Scandinavica.

[2]  A. Lo,et al.  Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER , 2016, Clinical neuropharmacology.

[3]  A. H. Ledinek,et al.  Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients , 2015, Clinical Neurology and Neurosurgery.

[4]  Moses Rodriguez,et al.  Aspirin is Unlikely to Have A Clinically Meaningful Effect on Multiple Sclerosis-Related Fatigue: Data From a Randomized Controlled Trial (P7.245) , 2014 .

[5]  U. Rot,et al.  Evaluating the effects of amantadin, modafinil and acetyl-l-carnitine on fatigue in multiple sclerosis – result of a pilot randomized, blind study , 2013, Clinical Neurology and Neurosurgery.

[6]  V. Shaygannejad,et al.  Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study , 2012, Neurological research.

[7]  U. Zifko.  Management of Fatigue in Patients with Multiple Sclerosis , 2012, Drugs.

[8]  M. Daumer,et al.  HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis , 2011, Multiple sclerosis.

[9]  V. Shaygannejad,et al.  Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis? , 2009, Neurologia i neurochirurgia polska.

[10]  J. Liepert,et al.  Modafinil effects in multiple sclerosis patients with fatigue , 2009, Journal of Neurology.

[11]  J. De Keyser,et al.  Fatigue, depression and disability accumulation in multiple sclerosis: a cross‐sectional study , 2009, European journal of neurology.

[12]  A. Cross,et al.  Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study , 2007, Multiple sclerosis.

[13]  M. Clanet,et al.  Modafinil for fatigue in MS , 2005, Neurology.

[14]  B. Weinshenker,et al.  A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis , 2005, Neurology.

[15]  P. Pasqualetti,et al.  Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial , 2004, Journal of the Neurological Sciences.

[16]  M. Sliwinski,et al.  The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. , 1996, Archives of neurology.

[17]  A. Cross,et al.  Fatigue therapy in multiple sclerosis , 1995, Neurology.

[18]  B. Weinshenker,et al.  A double‐blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis , 1992, Neurology.

[19]  B. Weinshenker,et al.  A Randomized Controlled Trial of Amantadine in Fatigue Associated With Multiple Sclerosis , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.